drugset / Trial / NCT02068027
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of the study is to determine whether clonidine gel is an effective treatment for reducing the pain associated with painful diabetic neuropathy.
Timeline
- Start
- 2014-03
- Primary completion
- 2015-03
- Completion
- 2015-03
Outcome
Missed primary endpoint
registry analysis (superiority test); Clonidine Gel 0.1% vs Placebo; p = 0.4503; Mixed Models Analysis; note: MMRM imputing for missing data NCT02068027 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clonidine | Other / unclassified | 3.9 mg | Topical |